Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

7 Software Stocks to Buy for Growth

By Chris Lau, InvestorPlace Contributor

Investors should hold software companies forecast to report strong earnings growth. Here are seven software stocks to buy.

Where Is the Rebound for Fallen Canopy Growth Stock?

By Chris Lau, InvestorPlace Contributor

What are investors worried about ahead of the upcoming CGC earnings report? For many, it's the expectation of near-term losses.

Cannabis 2.0 May Reignite Rally in Aurora Cannabis Stock

By Chris Lau, InvestorPlace Contributor

ACB stock continued its long-term decline. But those holding out for better times are betting on Cannabis 2.0 bringing back the growth.

Why Ford Stock Is Set to Rise After 2020 Product Unveiling

By Chris Lau, InvestorPlace Contributor

Ford stock is down again now but 2020 is set to reinvigorate the company’s prospects. New line-ups in the SUV segment await.

Here’s What to Watch in the Bank of America Stock Earnings Report

By Chris Lau, InvestorPlace Contributor

Investors have very few expectations when Bank of America reports quarterly earnings. That is a missed opportunity.

Load More